Evidence map›Paper›PMID 11782989›Full record

ArticleAnnals of neurology2002

Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.

Christopher M Gomez, Ricardo A Maselli, Bhupinder P S Vohra, Manuel Navedo, Joel R Stiles, Pierre Charnet, Kelly Schott, Legier Rojas, John Keesey, Anthony Verity and 2 more

Abstract read
In one paragraph

Article in Annals of neurology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 71 citations in OpenAlex.

  1. Slow-Channel Congenital Myasthenic Syndrome Due toJournal of clinical neurology (Seoul, Korea) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Slow-channel myasthenia due to novel mutation in M2 domain of AChR delta subunit.Annals of clinical and translational neurology · 2019
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Skeletal muscle calpain acts through nitric oxide and neural miRNAs to regulate acetylcholine release in motor nerve terminals.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. What have we learned from the congenital myasthenic syndromes.Journal of molecular neuroscience : MN · 2010
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Christopher M GomezDepartment of Neurology, University of Minnesota, Minneapolis, MN 55455, USA.
Ricardo A Maselli
Bhupinder P S Vohra
Manuel Navedo
Joel R Stiles
Pierre Charnet
Kelly Schott
Legier Rojas
John Keesey
Anthony Verity
Robert W Wollmann
Jose Lasalde-Dominicci
University of Minnesota · USUniversity of Puerto Rico System · PRCentre de Recherche en Biologie cellulaire de Montpellier · FRNeurology, Inc · USPittsburgh Supercomputing Center · USUCLA Medical Center · USUniversity of California, Davis · USUniversity of Chicago · US

Funding

YEAST ER MOLECULAR CHAPERONE TRANSLOCATION: GENOME DATABANK HOMOLOGSP41RR006009 · NCRR · MELLON PITTS CORPORATION (MPC CORP) · PI KNOLL, ERIC · 1990 to 2011
$22.0M
ACETYLCHOLINE RECEPTOR GENES IN SLOW CHANNEL SYNDROMER01NS033202 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI GOMEZ, CHRISTOPHER MANUEL · 1995 to 2014
$4.5M
NCRR NIH HHS P41 RR006009NCRR NIH HHS RR 06009NINDS NIH HHS R01 NS033202NINDS NIH HHS R01 NS33202
6 · The paper itself

Abstract

We investigated the basis for a novel form of the slow-channel congenital myasthenic syndrome presenting in infancy in a single individual as progressive weakness and impaired neuromuscular transmission without overt degeneration of the motor endplate. Prolonged low-amplitude synaptic currents in biopsied anconeus muscle at 9 years of age suggested a kinetic disorder of the muscle acetylcholine receptor. Ultrastructural studies at 16 months, at 9 years, and at 15 years of age showed none of the typical degenerative changes of the endplate associated with the slow-channel congenital myasthenic syndrome, and acetylcholine receptor numbers were not significantly reduced. We identified a novel C-to-T substitution in exon 8 of the delta-subunit that results in a serine to phenylalanine mutation in the region encoding the second transmembrane domain that lines the ion channel. Using Xenopus oocyte in vitro expression studies we confirmed that the deltaS268F mutation, as with other slow-channel congenital myasthenic syndrome mutations, causes delayed closure of acetylcholine receptor ion channels. In addition, unlike other mutations in slow-channel congenital myasthenic syndrome, this mutation also causes delayed opening of the channel, a finding that readily explains the marked congenital weakness in the absence of endplate degeneration. Finally, we used serial morphometric analysis of electron micrographs to explore the basis for the progressive weakness and decline of amplitude of endplate currents over a period of 14 years. We demonstrated a progressive widening and accumulation of debris in the synaptic cleft, resulting in loss of efficacy of released neurotransmitter and reduced safety factor. These studies demonstrate the role of previously unrecognized mechanisms of impairment of synaptic transmission caused by a novel mutation and show the importance of serial in vitro studies to elucidate novel disease mechanisms.

Indexed as

AdolescentAmino Acid SequenceAnimalsChildElectromyographyHumansIon Channel GatingMaleMolecular Sequence DataMotor EndplateMuscle WeaknessMutagenesis, Site-DirectedMyasthenic Syndromes, CongenitalNeuromuscular JunctionOocytesPatch-Clamp TechniquesReceptors, Nicotinic

Identifiers

PMID11782989
PMCPMC4841278
OpenAlexW2088175292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.